The interaction network of the proteasome assembly chaperone PSMD9 regulates proteostasis
The FEBS Journal · 2023
DOI: 10.1111/febs.16948 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2023. Verfasst von Joel Christie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Protein Interactome Lab for Structural and Functional Biology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, …. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Proteostasis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: NIGMS NIH HHS, Department of Atomic Energy, Government of India, Science and Engineering Research Board.
Abstract (Originalsprache)
Functional networks in cells are created by physical, genetic, and regulatory interactions. Mapping them and annotating their functions by available methods remains a challenge. We use affinity purification mass spectrometry (AP‐MS) coupled with SLiMFinder to discern such a network involving 26S proteasome non‐ATPase regulatory subunit 9 (PSMD9), a chaperone of proteasome assembly. Approximately 20% of proteins within the PSMD9 interactome carry a short linear motif (SLiM) of the type ‘EXKK’. The binding of purified PSMD9 with the peptide sequence ERKK, proteins heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNPA2B1; containing ERKK), and peroxiredoxin‐6 (PRDX6; containing EAKK) provided proof of principle for this motif‐driven network. The EXKK motif in the peptide primarily interacts with the coiled‐coil N domain of PSMD9, a unique interaction not reported for any coiled‐coil domain. PSMD9 knockout (KO) HEK293 cells experience endoplasmic reticulum (ER) stress and respond by increasing the unfolded protein response (UPR) and reducing the formation of aggresomes and lipid droplets. Trans‐expression of PSMD9 in the KO cells rescues lipid droplet formation. Overexpression of PSMD9 in HEK293 cells results in reduced UPR, and increased lipid droplet and aggresome formation. The outcome argues for the prominent role of PSMD9 in maintaining proteostasis. Probable mechanisms involve the binding of PSMD9 to binding immunoglobulin protein (BIP/GRP78; containing EDKK), an endoplasmic reticulum chaperone and key regulator of the UPR, and fatty acid synthase (FASN; containing ELKK), involved in fatty acid synthesis/lipid biogenesis. We propose that PSMD9 acts as a buffer in the cellular milieu by moderating the UPR and enhancing aggresome formation to reduce stress‐induced proteotoxicity. Akin to waves created in ponds that perpetuate to a distance, perturbing the levels of PSMD9 would cause ripples down the networks, affecting final reactions in the pathway, one of which is altered proteostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Protein Interactome Lab for Structural and Functional Biology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
- Homi Bhabha National Institute, Mumbai, India.
ORCID-Profile: Joel Christie, Prasanna Venkatraman
Förderung
- NIGMS NIH HHS
- Department of Atomic Energy, Government of India
- Science and Engineering Research Board
Zitieren
APA
Christie, J., Anthony, C. M., Harish, M., Mudartha, D., Ud Din Farooqee, S. B., & Venkatraman, P. (2023). The interaction network of the proteasome assembly chaperone PSMD9 regulates proteostasis. The FEBS Journal. https://doi.org/10.1111/febs.16948
Vancouver
Christie J, Anthony CM, Harish M, Mudartha D, Ud Din Farooqee SB, Venkatraman P. The interaction network of the proteasome assembly chaperone PSMD9 regulates proteostasis. The FEBS Journal. 2023. doi:10.1111/febs.16948
BibTeX
@article{Christie2023,
author = {Christie, Joel and Anthony, C Merlyn and Harish, Mahalakshmi and Mudartha, Deepti and Ud Din Farooqee, Sheikh Burhan and Venkatraman, Prasanna},
title = {The interaction network of the proteasome assembly chaperone PSMD9 regulates proteostasis},
journal = {The FEBS Journal},
year = {2023},
doi = {10.1111/febs.16948}
}
EUVIMED